Name: Retatrutide 30mg - Retlira 30
Brand: Pure Health
Price: 1450.00 AED
Availability: InStock

AED 1,450.00

Retlira 30 (Retatrutide) represents the next generation of metabolic management, offering a powerful, single-molecule solution for individuals committed to achieving profound, sustained body transformation and optimal metabolic health. As a triple-receptor agonist, Retatrutide provides unparalleled control over the body’s fundamental energy pathways, moving beyond simple appetite suppression to actively reset and optimize your metabolism.

Unmatched Efficacy: Retatrutide activates the receptors for GLP-1, GIP, and Glucagon simultaneously, driving a synergistic effect that results in superior, clinically-significant weight reduction and body composition changes.
Active Fat Metabolism: Unlike conventional treatments, the inclusion of Glucagon agonism actively promotes lipolysis (fat breakdown) and elevates resting energy expenditure, ensuring the body utilizes stored fat more efficiently.
Total Metabolic Control: Stabilize blood sugar, dramatically improve insulin sensitivity, and optimize lipid profiles, leading to a comprehensive reset of cardiometabolic health markers.
High-Potency Formula: This 30mg dose is engineered for maximum physiological impact, delivering the most comprehensive metabolic support available in its class.

Retlira 30 is the definitive choice for those seeking the ultimate solution to unlock their lowest set-point and optimize long-term health.

Week 1: 2.5mg (25 Clicks)
Week 2: 5mg (50 Clicks)
Week 3: 5mg (50 Clicks)
Week 4: 7.5mg (75 Clicks)

Retatrutide is designed for once-weekly administration, meaning a single injection provides continuous therapeutic coverage for an entire week.

Store in fridge, Do No Freeze.
Keep pen capped and clean.

Individuals with a Personal or Family History of Medullary Thyroid Carcinoma (MTC)
Individuals with Pancreatitis
Individuals with Severe Gastrointestinal Disease
Pregnancy and Breastfeeding
Individuals with Severe Kidney or Liver Impairment

These side effects are typically temporary and decrease in frequency and severity over time as the body adjusts to the medication.

Nausea: Very common, often occurring immediately after the injection or during mealtime.
Vomiting: Can occur, particularly if meals are consumed too quickly or are excessively fatty.
Diarrhea or Constipation: Changes in bowel habits are frequent.
Abdominal Pain: Discomfort or cramping in the stomach area.

Retatrutide (LY3437943) - 30mg

Retatrutide (Retlira 30) is an investigational compound and is not currently approved by major regulatory bodies (such as the FDA or EMA) for clinical use outside of authorized research trials. This product is a highly potent peptide and should be handled and administered with extreme caution.